Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1348 of 6351
-
Can a chemical rinse speed healing of abdominal abscesses?
Disease control Not yet recruitingThis is a single center, two arm phase I/II clinical trial exploring the use of chemical sclerosants (ethanol and povidone iodine) in decreasing the time needed for catheter drainage for patients with non-fistulous intraabdominal abscesses. The target study sample size is 60 pati…
Phase 1/2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could a $4 blood pressure pill boost brain energy in Parkinson's?
Disease control Not yet recruitingThis study investigates if Terazosin can improve metabolism in PD.
Phase 2 • Sponsor: Nandakumar Narayanan • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Personalized dosing may boost lupus kidney remission
Disease control Not yet recruitingSystemic lupus erythematosus (SLE) is an inflammatory, chronic, and multisystem autoimmune disease characterized by periods of activity and remission. Lupus nephritis (LN) is the most frequent renal complication and is associated with high morbidity, manifesting as nephritic or n…
Sponsor: Federal University of Maranhao • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Zoom-Based stress relief may slow aging in breast cancer survivors
Symptom relief Recruiting nowThe purpose of this research study to find out if a program called Remotely-delivered Cognitive Behavioral Stress Management (R-CBSM) can help women with breast cancer in the period of survivorship after they have completed treatment. This is a group stress management program don…
Sponsor: University of Miami • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Chemo shot straight into tumor could cut side effects
Disease control Not yet recruitingThe addition of intravenous (given through a vein) cisplatin to immunotherapy improves treatment outcomes for lung cancer, but unfortunately results in significantly more side effects since the rest of the body is exposed to significant amounts of the drug. Our clinical trial dat…
Phase 1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Shockwaves to the neck: new device aims to make artery stenting safer
Disease control Not yet recruitingProspective, Multi-center, Single-arm Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Femoral stenting (SKYWARD Trans-Femoral IDE Study)
Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Mouth spray may stop radiation burns in cancer patients
Prevention Not yet recruitingThis is a prospective, open-label, randomized, controlled, multicenter phase II study evaluating the efficacy and safety of Kangfu Spray for the prevention of radiation-induced oral mucositis in patients with histologically confirmed oral malignancies receiving intensity-modulate…
Sponsor: YE ZHANG • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
Brain training app takes on long COVID disability
Symptom relief Not yet recruitingThe goal of this study is to determine whether the SuperCAP intervention program is superior to control in reducing disability from baseline to the post-intervention assessment in people with Post-COVID-19 Condition. The main question it aims to answer is whether participants as…
Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Can a Seaweed-Derived supplement boost lung rehab in COPD?
Disease control Not yet recruitingThe goal of this clinical trial is to investigate whether an astaxanthin-based dietary supplement combined with a pulmonary rehabilitation training program could improve exercise capacity in patients with COPD. The main questions it aims to answer are: • whether an astaxanthin-b…
Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Mindfulness may help tame alcohol cravings by reconnecting body and mind
Disease control Recruiting nowThe goal of this clinical trial is to learn if a body-focused mindfulness program can help people with alcohol use disorder (AUD) feel more connected to their bodies and manage their emotions better. The main questions it aims to answer are: Does the mindfulness program reduce f…
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Belly fat melting shot? phase 3 trial begins.
Disease control Not yet recruitingA phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat.
Phase 3 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Electric implant aims to ease Amputees' lingering pain
Symptom relief Not yet recruitingThis is a single-center, prospective, within-subject study. This study seeks to enroll a total of 32 prospective subjects who will undergo surgical implantation of the FDA-approved Altius® system. Subjects will be followed longitudinally and will complete a series of patient-repo…
Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Glow-in-the-Dark cancer detector aims to cut repeat breast surgeries
Disease control Not yet recruitingThis is a minimal risk post-market registry study conducted at participating clinical institutions that are utilizing LumiSystem consistent with the U.S. Food and Drug Administration (FDA) approved indication for use to collect data on the use of LumiSystem in a real-world settin…
Sponsor: Lumicell, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New CAR-T therapy RN9101 targets Hard-to-Treat myeloma
Disease control Not yet recruitingThis is a single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability, preliminary efficacy, pharmacokinetics, pharmacodynamics and immunogenicity of RN9101 injection for patients with relapsed/refractory multiple myeloma.
Early phase 1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can two antibiotics beat one for Drug-Resistant typhoid?
Disease control Not yet recruitingThis randomized controlled trial will compare the effectiveness of single-drug therapy (meropenem) versus combination therapy (meropenem plus azithromycin) in children aged 2-16 years diagnosed with extensively drug-resistant (XDR) typhoid fever at the Children's Hospital, Lahore…
Sponsor: Iqra Asghar Ali • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for bile duct cancer: drug duo targets tough tumors
Disease control Not yet recruitingBiliary tract carcinoma (BTC), including cholangiocarcinoma and gallbladder cancer, is a highly aggressive digestive system malignancy with limited treatment options after failure of first-line standard chemotherapy. This open-label, single-arm, Phase II exploratory study aims t…
Phase 2 • Sponsor: HuiKai Li • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Simple blood tests could spot liver cancer earlier in diabetics
Disease control Not yet recruitingLiver cancer is a significant malignancy in Taiwan. With the widespread implementation of antiviral therapies, hepatitis B and C-related liver cancer has gradually declined; however, metabolic dysfunction-associated liver cancer continues to increase, particularly among patients …
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New pacing technique could improve heart function in AF and heart failure patients
Disease control Not yet recruitingThis is a prospective, multicenter, randomized controlled trial comparing Left Bundle Branch Area Pacing (LBBAP)-based cardiac resynchronization therapy (CRT) with conventional coronary sinus (CS) lead-based CRT in patients with permanent atrial fibrillation (AF) and heart failur…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
AI coach for parents of autistic kids: could a virtual simulation improve Real-Life communication?
Symptom relief Not yet recruitingThis randomized controlled trial evaluates an AI-based parental simulation designed to support reflective parenting, emotional regulation, and parent-child communication among parents of autistic children aged 3 to 12 years. A total of 140 parents will be recruited through an ext…
Sponsor: University of Haifa • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Experimental CAR T-Cell therapy targets tough lymphoma
Disease control Not yet recruitingThis is an investigator-initiated, prospective, open-label exploratory clinical study designed to evaluate the safety and preliminary efficacy of GoFast CD19 CAR T-cell therapy in adult patients with recurrent or refractory B-cell lymphoma. Eligible patients will undergo screenin…
Early phase 1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC